| | | | | |
ORMP Oramed Pharmaceuticals Inc. | $5,0750 | +4,64% | $209,23M | $99,72K | |
OSG Octave Specialty Group, Inc. | $4,5450 | +0,11% | $209,03M | $319,22K | |
| $62,9100 | +2,36% | $208,63M | $10,11K | |
| $5,8800 | -0,51% | $208,50M | $264,20K | |
ANTA Antalpha Platform Holding Company Class A Ordinary Shares | $3,7350 | -4,23% | $208,49M | $291,00 | |
CMRC Commerce.com, Inc. Series 1 Common Stock | $2,4650 | +4,45% | $207,14M | $376,93K | |
CHCI Comstock Holding Companies, Inc. Class A | $20,1350 | +1,49% | $206,15M | $11,83K | |
AESP Aeon Acquisition I Corp. Class A Ordinary Shares | $9,9700 | -0,01% | $206,11M | $113,00K | |
TVIV Texas Ventures Acquisition IV Corp Class A Ordinary Shares | $9,9400 | +0,20% | $205,42M | $40,00 | |
NPV Nuveen Virginia Quality Municipal Income Fund | $10,2880 | -0,60% | $205,21M | $69,97K | |
WLII Willow Lane Acquisition Corp. II Class A Ordinary Shares | $10,2450 | -0,15% | $204,71M | $12,00 | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2,6050 | +0,58% | $204,65M | $209,07K | |
| $7,2400 | +1,97% | $204,50M | $37,77K | |
ANGI Angi Inc. Class A Common Stock | $4,8850 | +4,72% | $204,40M | $330,48K | |
| $7,2750 | -0,75% | $203,13M | $72,45K | |
